-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on NextCure, Lowers Price Target to $3

Benzinga·03/07/2025 12:26:05
Listen to the news
HC Wainwright & Co. analyst Emily Bodnar reiterates NextCure (NASDAQ:NXTC) with a Buy and lowers the price target from $4 to $3.